Ajanta Pharma Ltd

Ajanta Pharma Share Pledge

Aayush Agrawal (Trustee of Aayush Agrawal Trust) has released a pledge on 1,736,353 equity shares of Ajanta Pharma Limited. This follows loan repayment.

Ajanta Pharma Share Pledge

Promoter Aayush Agrawal Trust released pledge on 9.76 lakh shares and created a new pledge on 9.20 lakh shares of Ajanta Pharma Limited.

Ajanta Pharma Share Pledge

Promoter Ravi Agrawal, as trustee of Ravi Agrawal Trust, released a pledge on 54,796 equity shares of Ajanta Pharma Limited due to excess pledge.

Ajanta Pharma Earnings Call Transcript: Key Takeaways

Ajanta Pharma reports strong Q1 FY27 results, but management remains cautious about sustainability, guiding for normalization in the US and acknowledging geopolitical headwinds in Asia.

Call

Guides 18% growth

Ajanta Pharma Employee Stock Options

Ajanta Pharma Limited has allotted 23,400 equity shares following the exercise of employee stock options. Consequently, the company's paid-up share capital increased to Rs. 24.99 Crore.

Ajanta Pharma Dividend

Ajanta Pharma Limited has fixed August 5, 2026, as the record date. This date determines shareholder eligibility for the payment of the first interim dividend.

Ajanta Pharma Q1 FY27 Results: Net Profit ₹334.2 Cr, Up 30.9% YoY

Ajanta Pharma Ltd reported revenue from operations of ₹1,626 Cr (+24.8% YoY) and net profit of ₹334.2 Cr (+30.9% YoY) for Q1 FY27.

Key figure

Net profit ₹334.2 Cr · +30.9% YoY

Ajanta Pharma Share Pledge

Ajanta Pharma promoter Aayush Agrawal released a pledge of 21,61,067 shares and simultaneously created a new pledge for the same number of shares.

Ajanta Pharma Board Meeting Date

Ajanta Pharma has scheduled a board meeting for July 30, 2026. The board will consider and approve the Q1 financial results.

Ajanta Pharma Annual General Meeting

Ajanta Pharma concluded its 47th AGM on July 16, 2026. Key resolutions included adopting FY2025-26 financial statements and confirming the interim dividend as final.

Ajanta Pharma Share Pledge

Ajanta Pharma revised its SAST filing, indicating pledged promoter shares as security for non‑convertible debentures. No monetary value of the pledge is disclosed.